Arantes Ana Carolina, Sousa Ana Luiza Lima, Vitorino Priscila Valverde de O, Jardim Paulo Cesar B Veiga, Jardim Thiago de Souza Veiga, Rezende Jeeziane Marcelino, Lelis Ellen de Souza, Rodrigues Rafaela Bernardes, Coca Antonio, Barroso Weimar Kunz Sebba
Universidade Federal de Goiás - Faculdade de Medicina - Programa de Pós-Graduação em Ciências da Saúde, Goiânia, GO - Brasil.
Universidade Federal de Goiás - Liga de Hipertensão Arterial, Goiânia, GO - Brasil.
Arq Bras Cardiol. 2020 May-Jun;114(3):554-561. doi: 10.36660/abc.20180426.
Although the effects of salt intake reduction on casual blood pressure have been extensively studied in hypertensive individuals, data on reductions of added salt on arterial stiffness in both normotensive and prehypertensive subjects are scarce.
To evaluate the effects of progressive reduction in added salt intake (from 6 grams to 4 grams per day) on peripheral and central blood pressure and arterial stiffness in normotensive, prehypertensive and hypertensive individuals.
This was a single-blinded clinical trial with 13 weeks of follow-up. Normotensive (≤ 130/85 mmHg), prehypertensive (≥ 130 e < 139/≥ 85 e < 90 mmHg) and stage 1 hypertensive individuals (< 139/≥ 85 and < 90 mmHg) were assessed. Casual blood pressure measurements and ambulatory blood pressure monitoring were performed using the automated OMRON 705CP device, and central blood pressure was measured using the Sphygmocor®. Twenty-four-hour urinary sodium excretion and the amounts of added salt consumed were measured. Statistically significance level was set at p < 0.05 for all analysis.
A total of 55 participants (18 normotensive, 15 prehypertensive and 22 hypertensive), median age 48 years (IQR:39-54) were studied. The groups were not different in age or sex. No difference was observed in blood pressure or sodium excretion levels before and after the intervention. No significant changes in arterial stiffness parameters were observed.
The progressive reduction in added salt intake during a period of 13 weeks did not cause significant reductions in peripheral and central blood pressure. (Arq Bras Cardiol. 2020; 114(3):554-561).
尽管减少盐摄入量对高血压患者偶然血压的影响已得到广泛研究,但关于减少添加盐对正常血压和高血压前期受试者动脉僵硬度影响的数据却很少。
评估逐步减少添加盐摄入量(从每天6克降至4克)对正常血压、高血压前期和高血压个体外周和中心血压以及动脉僵硬度的影响。
这是一项为期13周随访的单盲临床试验。评估了正常血压(≤130/85 mmHg)、高血压前期(≥130且<139/≥85且<90 mmHg)和1期高血压个体(<139/≥85且<90 mmHg)。使用自动欧姆龙705CP设备进行偶然血压测量和动态血压监测,并使用Sphygmocor®测量中心血压。测量24小时尿钠排泄量和摄入的添加盐量。所有分析的统计学显著性水平设定为p<0.05。
共研究了55名参与者(18名正常血压者、15名高血压前期者和22名高血压者),中位年龄48岁(IQR:39 - 54)。各组在年龄或性别上无差异。干预前后血压或钠排泄水平未观察到差异。未观察到动脉僵硬度参数有显著变化。
在13周期间逐步减少添加盐摄入量并未导致外周和中心血压显著降低。(《巴西心脏病学杂志》。2020;114(3):554 - 561)